Published in TZ Latest News
11 March, 2016 by The TZ Newswire Staff
Regeneron/Sanofi Drug Beats Humira In Rheumatoid Arthritis Trial
A drug candidate that Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) jointly developed has beaten AbbVie’s (ABBV) best-selling rheumatoid-arthritis (RA) drug in a late-stage study, the companies said Friday.